Since epigenetic regulation plays a role in SCLC transcriptional state of many immune-related genes, different studies propose histone deacetylase (HDAC) inhibitors as a strategy to reactivate STING pathway and immune infiltration in SCLC cell models [63, 92] (Fig. 1). Here, HDAC9 is linked to small cell lung carcinoma.